168 related articles for article (PubMed ID: 35960050)
1. Transformation from polycythemia vera to acute promyelocytic leukemia: Case report and literature review.
Li WW; Sui XF; Fan S; Xu H; Wang CL; Wang FY; Mo XD
Medicine (Baltimore); 2022 Aug; 101(32):e30064. PubMed ID: 35960050
[TBL] [Abstract][Full Text] [Related]
2. Clinical characteristics of a patient with
Jiang YZ; Wei ZL; Wang NN; Huang C; Huang J; Yan JW; Wang R; Yu ZZ; Huang DP
Hematology; 2022 Dec; 27(1):1290-1293. PubMed ID: 36476114
[TBL] [Abstract][Full Text] [Related]
3. [Novel method in diagnosis of chronic myeloproliferative disorders--detection of JAK2 mutation].
Rajnai H; Bödör C; Reiniger L; Timár B; Csernus B; Szepesi A; Csomor J; Matolcsy A
Orv Hetil; 2006 Nov; 147(45):2175-9. PubMed ID: 17402211
[TBL] [Abstract][Full Text] [Related]
4. Neutropenia caused by hairy cell leukemia in a patient with myelofibrosis secondary to polycythemia vera: a case report.
Habberstad AH; Tran HTT; Randen U; Spetalen S; Dybedal I; Tjønnfjord GE; Dahm AEA
J Med Case Rep; 2018 Apr; 12(1):105. PubMed ID: 29685167
[TBL] [Abstract][Full Text] [Related]
5. Transformation from acute promyelocytic leukemia in pregnancy to acute myeloid leukemia with MLL-AF9 fusion gene: A case report and literature review.
Gao Y; Han N; Jiang Y; Lu Z
Medicine (Baltimore); 2023 Dec; 102(48):e36403. PubMed ID: 38050244
[TBL] [Abstract][Full Text] [Related]
6. Two successful deliveries of healthy children by a young woman diagnosed and treated during induction and relapsed therapy for acute promyelocytic leukemia.
Dang CC; Guan YK; Lau NS; Chan SY
J Oncol Pharm Pract; 2020 Dec; 26(8):2034-2037. PubMed ID: 32279594
[TBL] [Abstract][Full Text] [Related]
7. [Significance of the JAK2V617F mutation in patients with chronic myeloproliferative neoplasia].
Iványi JL; Marton E; Plander M
Orv Hetil; 2011 Nov; 152(45):1795-803. PubMed ID: 22011365
[TBL] [Abstract][Full Text] [Related]
8. Disruption of the ASXL1 gene is frequent in primary, post-essential thrombocytosis and post-polycythemia vera myelofibrosis, but not essential thrombocytosis or polycythemia vera: analysis of molecular genetics and clinical phenotypes.
Stein BL; Williams DM; O'Keefe C; Rogers O; Ingersoll RG; Spivak JL; Verma A; Maciejewski JP; McDevitt MA; Moliterno AR
Haematologica; 2011 Oct; 96(10):1462-9. PubMed ID: 21712540
[TBL] [Abstract][Full Text] [Related]
9. Acute promyelocytic leukemia with myelofibrosis: A case report and literature review.
Xiao M; Qin L; Niu X; Zhou P; Niu J; Wei S; Li D; Dou L; Zhang W; Zhang L; Sun K; Bai Y
Medicine (Baltimore); 2021 Apr; 100(13):e24567. PubMed ID: 33787572
[TBL] [Abstract][Full Text] [Related]
10. Megakaryocytic morphology and clinical parameters in essential thrombocythemia, polycythemia vera, and primary myelofibrosis with and without JAK2 V617F.
Vytrva N; Stacher E; Regitnig P; Zinke-Cerwenka W; Hojas S; Hubmann E; Porwit A; Bjorkholm M; Hoefler G; Beham-Schmid C
Arch Pathol Lab Med; 2014 Sep; 138(9):1203-9. PubMed ID: 25171702
[TBL] [Abstract][Full Text] [Related]
11. BCR-ABL1- positive chronic myeloid leukemia with erythrocytosis presenting as polycythemia vera: a case report.
Cornea MI; Levrat E; Pugin P; Betticher DC
J Med Case Rep; 2015 Apr; 9():30. PubMed ID: 26187587
[TBL] [Abstract][Full Text] [Related]
12. Extensive Hepatic Infarction due to Polycythemia Vera.
Furukawa K; Urano F; Okamura S; Kawashima H
J Gastrointestin Liver Dis; 2024 Mar; 33(1):18. PubMed ID: 38554424
[TBL] [Abstract][Full Text] [Related]
13. Oral arsenic plus retinoic acid versus intravenous arsenic plus retinoic acid for non-high-risk acute promyelocytic leukaemia: a non-inferiority, randomised phase 3 trial.
Zhu HH; Wu DP; Du X; Zhang X; Liu L; Ma J; Shao ZH; Ren HY; Hu JD; Xu KL; Wang JW; Song YP; Fang MY; Li J; Yan XY; Huang XJ
Lancet Oncol; 2018 Jul; 19(7):871-879. PubMed ID: 29884593
[TBL] [Abstract][Full Text] [Related]
14. Translocation (1;20)(q32;q13.3) in myelofibrosis following polycythemia vera.
Davidovitz Y; Lev D; Ballin A; Tsudik A; Meytes D
Cancer Genet Cytogenet; 1998 Mar; 101(2):156-8. PubMed ID: 9494620
[TBL] [Abstract][Full Text] [Related]
15. Transformation from acute promyelocytic leukemia to acute myeloid leukemia with a CEBPA double mutation: A case report and review of the literature.
Sun Y; Wang C; Sun Y; Wang J; Rong C; Wu A; Ouyang G; Sheng L
Medicine (Baltimore); 2021 Feb; 100(5):e24385. PubMed ID: 33592885
[TBL] [Abstract][Full Text] [Related]
16. Narrative review: Thrombocytosis, polycythemia vera, and JAK2 mutations: The phenotypic mimicry of chronic myeloproliferation.
Spivak JL
Ann Intern Med; 2010 Mar; 152(5):300-6. PubMed ID: 20194236
[TBL] [Abstract][Full Text] [Related]
17. Transformation of polycythemia vera to acute promyelocytic leukemia.
Kajiguchi T; Simokawa T; Saito M; Takeyama H
Int J Hematol; 2000 Dec; 72(4):520-1. PubMed ID: 11197225
[No Abstract] [Full Text] [Related]
18. The role of JAK2 V617F mutation, spontaneous erythropoiesis and megakaryocytopoiesis, hypersensitive platelets, activated leukocytes, and endothelial cells in the etiology of thrombotic manifestations in polycythemia vera and essential thrombocythemia.
Bellucci S; Michiels JJ
Semin Thromb Hemost; 2006 Jun; 32(4 Pt 2):381-98. PubMed ID: 16810614
[TBL] [Abstract][Full Text] [Related]
19. The diagnosis and management of polycythemia vera, essential thrombocythemia, and primary myelofibrosis in the JAK2 V617F era.
Zhan H; Spivak JL
Clin Adv Hematol Oncol; 2009 May; 7(5):334-42. PubMed ID: 19521323
[TBL] [Abstract][Full Text] [Related]
20. Changing concepts of diagnostic criteria of myeloproliferative disorders and the molecular etiology and classification of myeloproliferative neoplasms: from Dameshek 1950 to Vainchenker 2005 and beyond.
Michiels JJ; Berneman Z; Schroyens W; De Raeve H
Acta Haematol; 2015; 133(1):36-51. PubMed ID: 25116092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
